MAIA Biotechnology, Inc. (MAIA)
NYSEAMERICAN: MAIA · Real-Time Price · USD
1.325
-0.055 (-3.99%)
Aug 28, 2026, 3:12 PM EDT - Market open
MAIA Biotechnology Market Cap
MAIA Biotechnology has a market cap or net worth of $80.59 million as of August 28, 2026. Its market cap has increased by 48.05% in one year.
Market Cap
80.59M
Enterprise Value
53.00M
1-Year Change
48.05%
Ranking
Category
Stock Price
$1.33
ChartMarket Cap Chart
Since the IPO on July 28, 2022, MAIA Biotechnology's market cap has increased from $51.10M to $80.59M, an increase of 57.72%. That is a compound annual growth rate of 11.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 80.59M | 37.66% |
| Dec 31, 2025 | 58.55M | 13.04% |
| Dec 31, 2024 | 51.79M | 161.26% |
| Dec 29, 2023 | 19.82M | -48.40% |
| Dec 30, 2022 | 38.42M | -24.81% |
| Jul 28, 2022 | 51.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rallybio | 89.00M |
| Verrica Pharmaceuticals | 87.10M |
| Gossamer Bio | 83.15M |
| Telomir Pharmaceuticals | 81.84M |
| OKYO Pharma | 81.34M |
| Gain Therapeutics | 80.74M |
| Alterity Therapeutics | 79.50M |
| Cingulate | 79.11M |